Adherence to treatment in paediatric patients – results of the nationwide survey in Poland

Abstract

Background Due to high prevalence, non-adherence to prescribed treatment seriously undermines the effectiveness of evidence-based therapies in paediatric patients. In order to change this negative scenario, physicians need to be aware of adherence problem, as well as of possible solutions. Unfortunately, full potential of adherence-targeting interventions is still underused in Poland. Therefore, the aim of this study was to assess the knowledge, attitudes and behaviours toward non-adherence in Polish paediatricians. Methods An anonymous cross-sectional nationwide survey was conducted in the convenience sample of Polish doctors providing care to paediatric patients. The survey focused on the prevalence of non-adherence, its causes, and interventions employed. Primary studied parameter was perceived prevalence of non-adherence in paediatric patients. Reporting of this study adheres to STROBE guidelines. Results One thousand and thirty-three responses were eligible for analysis. Vast majority of respondents were female (85.9%), most of them worked in primary care (90.6%). The respondents represented all 16 Polish Voivodeships, with the biggest number coming from the Mazowieckie Voivodeship (n = 144, 13.9%). Survey participants believed that on average 28.9% of paediatric patients were non-adherent to medication. More than half of the respondents (n = 548, 53.0%) were convinced that their own patients were more adherent than average. Duration of the professional practice strongly correlated with a lower perceived prevalence of non-adherence. Professionals with more than 40 years of practice believed that the percentage of non-adherent patients was <=20% particularly often (OR = 3.82 (95% CI 2.11–6.93) versus those up to 10 years in practice). Out of all respondents, they were also most often convinced that their own patients were more adherent than the general population (P < 0.01). Consequently, they underestimated the need for training in this area. Conclusions Physicians taking care of Polish paediatric patients underestimated the prevalence of medication non-adherence and believed that this was a problem of other doctors. This optimistic bias was particularly pronounced in older doctors. These results identify important barriers toward improving patient adherence that are worth addressing in the pre- and post-graduate education of Polish physicians. They also put some light over the challenges that educational activities in this area may face.

Aspirin Responsiveness in a Cohort of Paediatric Patients With Bovine Jugular Venous Valves and Right Ventricle to Pulmonary Artery Conduits

“…but adherence may be underestimated in the paediatric population [30]. Pharmacodynamic resistance in which there is adequate bioavailability of aspirin but no inhibition in-vitro appears to be rare, especially that which cannot be overcome by dose increase [2,19,25,26,28].…”

Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?

“…Along with these principal aims, other areas of CoEs’ activities are worth considering, such as clinical practice, e.g., promoting the use of the best evidence-based interventions and implementation strategies and introducing novel technologies for medication adherence management. Due to the accumulation of unique knowledge and experience, CoEs will be able to provide professional education to healthcare providers in medication adherence management, responding to the well-defined need of this group of stakeholders [ 8 ]. Similarly, CoEs are perfectly placed to provide professional communication to the general public and, last but not least, advocacy.…”

“…This, however, is not fully reflected in clinical practice, where more than 50 years of dedicated research has not yet led to any breakthrough. In consequence, medication adherence rates remain suboptimal, and many healthcare professionals do not want to admit that medication non-adherence is a problem nor to implement available interventions [ 8 ].…”

Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies

“…Allergic medication non-adherence has been considered by the World Health Organization (WHO) as a global public problem with significant consequences [123]. It is a multifaceted problem involving the patients, caregivers, and interdisciplinary healthcare team [124].…”